-
www.ahrq.gov/sites/default/files/2024-01/lo-report.pdf
January 01, 2024 - Final Progress Report: Clinical Prediction of Hepatotoxicity & Comparative Hepatic Safety of Medications
R01 HS18372: Clinical Prediction of Hepatotoxicity & Comparative Hepatic Safety of Medications
AHRQ Grant Final Progress Report
Title of Project: Clinical Prediction of Hepatotoxicity & Comparative Hepatic Safet…
-
www.ahrq.gov/sites/default/files/2024-12/romano-report.pdf
January 01, 2024 - Final Progress Report: Information about Quality in a Randomized Evaluation (INQUIRE)
1
FINAL PROGRESS REPORT
Information about Quality in a Randomized Evaluation (INQUIRE)
Principal Investigator:
Patrick S. Romano, MD MPH
Professor of Medicine and Pediatrics
University of California Davis School of Medicine …
-
www.ahrq.gov/sites/default/files/2025-04/schiff-mcnutt-report.pdf
January 01, 2025 - Final Progress Report: Cook County & Rush Developmental Center for Research in Patient Safety: Diagnosis Error Evaluation and Research (DEER) Project
Title:
Cook County & Rush Developmental Center for Research in Patient Safety:
Diagnosis Error Evaluation and Research (DEER) Project
Principal Investigator:
Gordon …
-
www.ahrq.gov/hai/cusp/toolkit/content-calls/framework.html
April 01, 2013 - CUSP: A Framework for Success (Transcript)
March 7, 2012
Operator: Excuse me, everyone, and thank you for holding, please be aware that each of your lines is in a listen-only mode. At the conclusion of today's presentation, we will open the floor for questions at that time. Instructions will be given as to t…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hyperactivity-disorder-protocol-amendment.pdf
January 08, 2025 - Diagnosis of Attention-Deficit/Hyperactivity Disorder in Adults: A Systematic Review
EPC Protocol Version 21, 3/4/2024
Evidence-based Practice Center Systematic Review Protocol
Project Title: Diagnosis of Attention-Deficit/Hyperactivity Disorder in Adults: A
Systematic Review
Initial public…
-
digital.ahrq.gov/sites/default/files/docs/hit-cdm-transcript-062111.pdf
June 16, 2021 - Using Health IT Chronic Disease Management
______________________________________________________________________________________
Using Health IT for Chronic Disease Management Page 1 of 22
NATIONAL WEB-BASED TELECONFERENCE ON HEALTH IT:
USING HEALTH IT FOR CHRONIC DISEASE MANAGEMENT
________…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review40/gonorrhea-screening-2005
May 15, 2005 - 4,324 men and women (PCR)
2,305 men and women (culture)
PCR (Amplicor® CT/NG)
FDA-listed … sites:
penile/urethral swabs
urine
cervical/vaginal swabs
Non FDA-listed sites … PCR for FDA-listed specimens (553 penile/urethral swabs, urine, and cervical/vaginal swabs): sensitivity … PCR for non FDA-listed specimens (827 ano-rectal, oropharyngeal and other specimen types): sensitivity
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2020_Core_Weighted.PDF
January 01, 2020 - 0.00 1.00 0.11 0.00 0.1034 0.1114
I10_INJURY Injury ICD-10-CM diagnosis reported on
record (1: First-listed … injury; 2: Other than
first-listed injury; 0: No injury)
16,692,694 0 0.00 2.00 0.12 0.00 0.1194 0.1254 … Percent
of Total
0: No injury diagnoses reported 29,510,175 91.26%
1: Injury is reported in first-listed … diagnosis 1,695,370 5.24%
2: Injury is reported in a diagnosis other than the first-listed diagnosis
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2020_CORE.PDF
January 01, 2020 - Minimum Maximum Mean Median Sum
I10_INJURY : Injury ICD-10-CM diagnosis reported on record (1:
First-listed … injury; 2: Other than first-listed injury; 0: No injury) 16,692,694 0 0.00 2.00 0.13 0 2,164,701
I10 … Percent
of Total
0: No injury diagnoses reported 15,144,420 90.72%
1: Injury is reported in first-listed … diagnosis 931,847 5.58%
2: Injury is reported in a diagnosis other than the first-listed diagnosis
-
www.ahrq.gov/teamstepps-program/resources/additional/index.html
September 01, 2023 - JavaScript is disabled
In order to continue, we need to verify that you're not a robot.
This requires JavaScript. Enable JavaScript and then reload the page.
-
effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_disposition-comments.pdf
February 29, 2016 - Each comment is listed with the name and affiliation of the commentator, if this information
is provided … past ACP guideline used a table with
headers stratified by pain duration and
then interventions and listed … A very few
concerns and comments are listed
below:
Line 15, page ES-34 typo
Thank you for the … Skin irritation is listed in this report, but
we have found it to be minimal.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
March 15, 2007 - Women age 40-74 y; local residents with new diagnosis of invasive cancer of the colon or rectum; listed … telephone number
Patients with listed telephone number and either a current Wisconsin driver's
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/EppFbhnDEX5UtYWrTkLEhT
March 01, 2007 - y Women age 40–74 y; local
residents with new
diagnosis of invasive
cancer of the colon or
rectum; listed … telephone
number
Patients with listed
telephone number and
either a current Wisconsin
driver’s license
-
integrationacademy.ahrq.gov/sites/default/files/2025-06/Innovations%20in%20Behavioral%20Health%20Integration_Transcript.docx
January 01, 2025 - Team that's listed here, as well as numerous groups involved
44
00:08:42.720 --> 00:08:50.790
Anna Ratzliff … is a global set of actually several different function measures that are included, and you see those listed
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
September 01, 2022 - is increasingly used to describe large volumes of either
routinely collected or customized data, as listed … tests, such as meta-regression and Cochran’s Q test, should
be used in concert with the considerations listed
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
September 01, 2022 - is increasingly used to describe large volumes of either
routinely collected or customized data, as listed … tests, such as meta-regression and Cochran’s Q test, should
be used in concert with the considerations listed
-
cdsic.ahrq.gov/sites/default/files/2023-08/User%20Guide_SMD%20Planning_%20Implementation_%20Reporting_508.pdf
January 01, 2023 - of the Scaling, Measurement, and Dissemination of CDS Workgroup who contributed to this
report are listed … It might not be feasible for organizations to describe (or address in implementation) every item listed
-
digital.ahrq.gov/sites/default/files/User%20Guide_SMD%20Planning_%20Implementation_%20Reporting_508.pdf
August 01, 2023 - of the Scaling, Measurement, and Dissemination of CDS Workgroup who contributed to this
report are listed … It might not be feasible for organizations to describe (or address in implementation) every item listed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
March 01, 2016 - We contacted manufacturers of the
prescription medications used to treat gout that are listed
in Table … for each conclusion (e.g., the
efficacy and safety of each pharmacologic agent or class
of agents listed
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/sepsis-1.pdf
March 01, 2020 - Chapter-3 - Sepsis Recognition
Sepsis Recognition 3-1
3. Sepsis Recognition
Authors: Bryan Gale, M.A., and Kendall K. Hall, M.D., M.S.
Introduction
Sepsis has been a leading cause of hospitalization and death in U.S. healthcare settings for many years,
and accounts for more hospital admissions and spending than…